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doi:10.1016/j.ejvs.2009.05.011Abstract Introduction: Previous studies indicate that local (LA) rather than general anaes-
thesia (GA) for carotid endarterectomy (CEA) is associated with reflex hypertension and pres-
ervation of cerebral cytochrome oxidase after carotid clamping. The hypothesis that LA offers
protection against ischaemic cerebral injury has been investigated by measuring ipsilateral
jugular venous neurone specific enolase (NSE: neuronal glycolytic enzyme) and S-100B (glial
cell protein) during and after CEA.
Methods: 27 patients with symptomatic carotid artery disease (70e99% stenosis) underwent
CEA, 14 under LA and 13 under GA. Jugular venous blood samples were assayed for NSE and
S-100B before carotid clamping and at 5 min before and 5 min, 2, 4, 6, 8, 12 and 24 h after
clamp release.
Results: No neurological complications occurred. S-100B levels were low and did not increase
from baseline in either group. Pre-clamp NSE levels were similar in both groups (LA: 17.6
(15.2e20.7) mg/l, GA: 21.5 (11.3e26.2) mg/l; pZ 0.37) but increased significantly 2 h after
clamp release in GA patients (LA: 25.5 (16.6e27.8) mg/l, GA: 48.2 (31.4e61.3) mg/l,
pZ 0.05) with a significant rise from baseline in GA patients (pZ 0.04).
Conclusions: CEA performed under GA is associated with greater rises in jugular venous NSE,
and hence cerebral injury, than CEA performed under LA.
ª 2009 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.3 392 2823; fax: þ44 113 392
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ty for Vascular Surgery. PublisheIntroduction
Although carotid endarterectomy (CEA) reduces the long
term risk of ischaemic stroke surgery may be complicated
by acute cerebral ischaemia.1,2 Its benefit depends on a low
complication rate and thus procedural modifications that
minimise ischaemic injury might be beneficial. In this
respect previous studies using near infrared spectroscopyd by Elsevier Ltd. All rights reserved.
Table 1 Clinical details of patients undergoing carotid
endarterectomy
GA (13) LA (14) p
Age (iqr) 67 (54e76) 68 (51e77) 0.77
Male 8 8 1.00
Hypertension 13 12 0.50
Diabetes Mellitus 3 4 1.00
Hyperlipidaemia 11 11 1.00
Current smoking 4 4 1.00
Aspirin 13 14 1.00
Anticoagulants 0 0 e
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cytochrome oxidase levels and perfusion during surgery
under local anaesthesia (LA) compared with general
anaesthesia (GA).3 These potential benefits were associ-
ated with a significant rise in systemic blood pressure in LA
patients following carotid clamping. However there are no
studies which examine the degree of cerebral injury asso-
ciated with different anaesthetic techniques.
One difficulty in assessing acute cerebral ischaemic
injury is the wide spectrum of changes that may occur,
varying from a clinically obvious stroke to subtle neuro-
psychological dysfunction. Thus, Vanninen et al.4 demon-
strated a deterioration in cognitive function in 63% of
patients one month after CEA with only 5% demonstrating
an overt neurological deficit. Further, the neuro-
psychological tests that quantify these effects may be
unreliable or difficult to interpretate because of the influ-
ence of general health status, anxiety and practice on the
results.5 More recently, specific brain-derived proteins such
as S-100B or neurone specific enolase (NSE) have been
proposed as neuro-biochemical markers of adverse neuro-
logical outcome.6 In a rat model of middle cerebral artery
occlusion a significant increase in circulating NSE levels
occurred 2 h after a focal ischaemic insult.7 Similarly serum
levels of these markers correlate with adverse neurological
outcomes after traumatic brain injury,8 cardiopulmonary
bypass9 and stroke.10 This affords an opportunity for
objective quantification of cerebral injury during CEA.
Despite these studies systemic NSE and S-100B levels in
patients undergoing CEA have failed to reflect clinical
outcome unless there was an obvious neurological deficit
rather than cognitive impairment.11e13 This could be
explained on the basis that isolated cognitive impairment is
a manifestation of minimal cerebral damage which may be
associated with lower and possibly transient increases in
serum markers that are undetectable in peripheral blood
samples.14 The hypothesis that LA offers greater protection
against ischaemic cerebral injury has thus been investi-
gated by measuring ipsilateral jugular venous NSE and
S-100B levels during and up to 24 h after CEA.
Methods
Patients
During 2001 27 consecutive patients were randomised as
part of the GALA Trial15 to undergo carotid endarterectomy
under general (nZ 13) or local anaesthesia (nZ 14). The
two groups were similar in terms of age, sex and the
presence of cardiovascular risk factors (Table 1). All had
a 70e99% ipsilateral symptomatic carotid stenosis (mean
stenosis 80% for both groups) as assessed by colour flow
duplex ultrasound (Acuson 128XP, California, USA), with
moderate narrowing of the contralateral internal carotid
artery (GA group average 30%, LA group average 40%).
Details of symptoms occurring during the preceding
6 months are shown in Table 2.
Anaesthesia
All patients received midazolam 2 mg iv either prior to
induction of general anaesthesia or administration of thelocal anaesthetic nerve block. Loco-regional anaesthesia
was achieved by a standard superficial cervical plexus block
using 20 ml 0.25% bupivacaine and 1/200000 adrenaline.
General anaesthesia was induced with fentanyl and
vecuronium, and maintained on a mixture of isoflurane
(0.6e1%), nitrous oxide (60%) and oxygen (40%). In those
patients receiving a GA, systemic blood pressure was
adjusted using an epinephrine infusion if it fell below the
preoperative blood pressure.
Surgery
A standard endarterectomy technique was used in all
patients. The carotid sinus was anaesthetised with 2 ml 1%
lignocaine before full dissection of the carotid vessels. The
external, internal and common carotid arteries were
clamped sequentially and a longitudinal arteriotomy and
endarterectomy performed. Distal tacking sutures were
inserted when necessary with routine closure of the
arteriotomy with a Dacron patch.
Monitoring
Patients were monitored with intra-arterial blood pressure,
pulse oximetry and electrocardiography. Mean stump
pressure was measured in all patients and those receiving
local anaesthesia were subjected to awake neurological
testing during cross clamping (squeezing a squeaky toy held
in the contralateral hand, move the contralateral lower
limb, perform simple mental arithmetic, to recite their
address, engage in regular conversation).
Shunting
Patients who received a GA were shunted if the mean
stump pressure was <50 mmHg. The primary indication for
shunt insertion in LA patients was deterioration in cerebral
function or the level of consciousness as assessed by awake
neurological testing.
Jugular venous sampling
The ipsilateral internal jugular vein was cannulated under
direct vision prior to carotid clamping and the tip of the
catheter (Vygon Leadercath: Vygon, Cirencester, UK)
placed in the jugular bulb. This remained in situ for 24 h.
Blood samples (5 ml) were obtained before carotid clamp-
ing, and 5 min before and 5 min, 2, 4, 6, 8, 12 and 24 h after
clamp release. Samples were placed in tubes without
anticoagulant. Blood was allowed to clot and after centri-
fugation (1000g for 10 min), separated serum was stored
at 80 C for later analysis.
Table 2 Details of carotid symptoms, stenosis and surgical technique
GA (13) LA (14) p
Symptom AF:3, CVA:4, TIA:7 AF:2, CVA:4, TIA:7 0.74
Last event, weeks 13 (6e20) 12 (6e20) 0.72
Ipsilateral stenosis, % 80 (75e90) 80 (75e90) 0.78
Contralateral stenosis, % 30 (20e50) 40 (20e50) 0.74
Contralateral occlusion 1 1 1.00
Abnormal vertebral flow 0 0 e
Carotid clamp time, min 48 (40e60) 50 (40e65) 0.78
Stump pressure, mmHg 49.1 (39e84) 48.5 (37e81) 0.73
Shunt 8 1 0.01
Patch 13 14 1.00
AF e Amaurosis fugax, CVA e stroke, TIA e transient ischaemic attack, DataZmedian iqr.
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Serum NSE and S-100B levels were measured (blind to
anaesthetic method) using an immuno-luminometric assay
and a fully automated LIA-mat system (AB Sangtec Medical,
Bromma, Sweden). Sangtec 100 measures the b-subunit of
S-100B as defined by 3 monoclonal antibodies. NSE was
measured using monoclonal antibodies that bind to the
g-subunit of the enzyme.
Clinical outcome
A standard neurological examination was performed 24 h
after surgery and prior to discharge from hospital.
The hospital research ethics committee approved this
project.
Statistical analysis
Significance of observed changes from baseline and between
different time points within each group was tested with
ANOVA and paired t tests. Numerical data between groups
were compared using the ManneWhitney U test because of
a ‘‘non-Gaussian’’ distribution and small sample size. Cate-
gorical data was compared by the Fisher exact test.
Results
No neurological complication occurred in these patients.
S-100B levels were low and did not change from baseline
levels in either group [baseline levels GA: 0.10 mg/l (0.08e
0.11), LA: 0.13 mg/l (0.12e0.17) [Fig. 1].0
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Figure 1 Jugular venous S-100B levels (ug/l; median iqr) dur
anaesthesia. Baseline levels (B): LA v GA, pZ 0.8. Baseline to peaPre-clamp NSE levels were similar in both groups [LA:
17.6 mg/l (15.2e20.7), GA: 21.5 mg/l (11.3e26.2); pZ 0.37].
Peak levels occurred 2 h after clamp removal and were
significantly higher in GA patients [LA: 25.5 mg/l (16.6e
27.8), GA: 48.2 mg/l (31.4e61.3), pZ 0.05,ManneWhitney].
At 2 h, the increase from baseline in the GA patients was
significant (pZ 0.04) andNSE levels remained elevated inGA
patients at all time points up to 12 h, returning to baseline at
24 h (Fig. 2).
Discussion
This study is the first to compare S-100B and NSE levels in
patients undergoing CEA with either LA or GA. It is also one
of a minority that has measured these potential markers of
cerebral injury in the jugular vein, rather than systemic
venous blood, throughout the study period. Thus the results
should more accurately define any changes that occur.
Clearly there was no difference in baseline NSE and
S-100B levels (pre-clamping) between GA or LA patients.
This remained the case during carotid clamping. Further,
although some reports have described a small but signifi-
cant increase in S-100B during clamping13,16 this did not
occur in the present study, a finding that concurs with
several others reports in patients undergoing uncompli-
cated GA12,14 or LA17 CEA. In contrast S-100B levels rise in
patients who develop a significant neurological deficit
following CEA or carotid angioplasty (CAS)12,13,18 and those
with impaired neuropsychometric testing post-operatively.19GALA
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Figure 2 Jugular venous NSE levels (ug/l; median iqr) during and after carotid endarterectomy under local or general
anaesthesia. Baseline levels: LA v GA, pZ 0.4. Baseline to peak: LA pZ ns; GA pZ 0.04. LA v GA at 2 h post-op: pZ 0.05.
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multiple embolic events during CAS also demonstrated
elevated levels of this protein.
Following cerebral reperfusion NSE levels increased
significantly in GA patients, peaking 2 h after carotid clamp
release. They remained elevated for 12 h following clamp
release (Fig. 2) and were significantly higher than in
patients receiving LA.
Elevated serum NSE levels reflect ischaemia-induced
cytoplasmic enzyme loss and are detectable before irre-
versible neuronal damage occurs. This rise in jugular venous
NSE levels following CEA under GA would be consistent with
previous work suggesting that LA better preserves cerebral
oxygenation and perfusion compared to GA.3 Such an
observation would support the concept that CEA under LA
might be associated with lower peri-operative stroke and
death rates. Whilst this is endorsed by a systematic review
of non-randomised and randomised studies20 the recently
published GALA Trial15 has failed to confirm this benefit. In
the latter stroke occurred in 4.0% (70/1752) of GA patients
and 3.7% (66/1771) of the LA group. Although the outcome
of such a large study might be expected to provide
conclusive evidence on the possible benefit of CEA per-
formed under LA, there were confounding factors. In
particular intra-operative blood pressure was pharmaco-
logically elevated in more GA patients (43% v 17%) thus
mimicking the post-clamping reflex hypertension that is
thought to be responsible for improved cerebral physiology
in LA patients.
S-100B is a protein found primarily in cerebral glial cells
and a rise in serum levels is specific to glial cell injury.6 The
results of this study therefore suggest that neuronal rather
than glial cell injury is more likely during CEA under GA
reflecting the greater susceptibility of the neuronal cells to
ischaemia. An alternative explanation for the different
patterns of NSE and S-100B release may have been limiting
venous sampling to 24 h post-operatively. In a previous
study correlating neuro-behavioural outcome after stroke
with serum S-100B, peak levels occurred on the second day
post-stroke, whereas serum NSE levels were maximal on
admission.10 This may reflect a delayed glial cell response
to ischaemia.A recent study by Brightwell et al.18 assessed systemic
NSE levels after CEA under LA and compared them with NSE
levels following carotid angioplasty and stenting (CAS).
Surprisingly, these authors found that NSE increased 6 h
post-CEA despite the avoidance of general anaesthesia.
Nevertheless the peri-operative stroke rate was high
(10.7%) and this may have distorted the results. Moreover,
systemic rather than jugular venous sampling makes
comparisons between the studies difficult, since systemic
arterial and venous S-100B levels are lower than those
measured in jugular venous blood.14,21
Jugular rather than systemic venous blood was
assayed to minimise dilutional effects and to obtain
blood principally derived from the ipsilateral cerebral
hemisphere. Although there is some mixing of venous
blood from the two hemispheres in the sigmoid sinus in
a steady state it can be assumed that the jugular venous
drainage from a particular side reflects metabolism in
the ipsilateral hemisphere. A similar technique has been
used previously to assess cerebral oxygen extraction
during CEA.22,23
Whilst it might be suggested that an increase in these
putative markers of cerebral injury following CEA under GA
is due to possible extracerebral effects of anaesthesia,
previous studies show no change in NSE levels following
abdominal aortic aneurysm repair11 or of S-100B after
thyroidectomy.24 Thus it is reasonable to assume that their
source is exclusively cerebral and is not influenced by GA
per se.
Currently there is increasing enthusiasm for carotid
angioplasty and stenting as an alternative to carotid
endarterectomy although there remains no good evidence
to prefer this over surgery in patients with a symptomatic
carotid stenosis. CAS is undoubtedly associated with more
intra-procedure embolic events18,25 and these appear to be
associated with higher S-100B levels, even in peripheral
blood.18
In summary this study shows that an acute increase in
jugular venous NSE levels is observed after CEA performed
under GA, but not after CEA performed under LA. This is
further evidence that during CEA, LA may provide some
protection against peri-operative cerebral injury.
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